Les plus grandes agences mondiales considèrent que les réunions de haut niveau des Nations Unies doivent accorder la priorité à l’oxygène médical afin de sauver des vies

Geneva/New York – In advance of the three UN High-Level Meetings on Pandemic Prevention, Preparedness and Response, Universal Health Coverage, and Tuberculosis 20-22 September 2023, about 20 of the world’s leading agencies call on world leaders to prioritize access to medical oxygen in health strategies, policies, and financing.

The Global Oxygen Alliance (GO2AL) was launched in May 2023 with Unitaid and the Global Fund to Fight AIDS, Tuberculosis and Malaria as co-chairs, the Pan American Health Organization (PAHO) and the Africa Centres for Disease Control and Prevention (Africa CDC) as vice-chairs, and Unitaid, the World Health Organization (WHO) and UNICEF sharing the secretariat. GO2AL is calling for world leaders to ensure the 2023 World Health Assembly Resolution on Increasing Access to Medical Oxygen, adopted by all 194 WHO Member States, is reflected in the universal health coverage, pandemic preparedness, prevention and response, and tuberculosis agendas.

“Medical oxygen is a lifesaving medicine that is essential to pandemic prevention, preparedness and response, achieving universal health coverage and the fight against tuberculosis. If we’re going to increase access and affordability of medical oxygen for the people who need it most, we need innovative ways of producing and delivering it, and tools adapted for use in low-resource settings,” said Philippe Duneton, Executive Director of Unitaid.

Medical oxygen is a lifesaving essential medicine without substitute, used to treat both acute and chronic respiratory illnesses, including COVID-19 and pneumonia. It is essential for surgery, trauma, emergency, critical care, and for treating older people, pregnant women with obstetric complications and newborns in respiratory distress; and can support the management of opportunistic infections due to advanced HIV infection and severe forms of tuberculosis and malaria, as well as non-communicable diseases such as chronic obstructive pulmonary disease and cardiovascular disease.

“Access to medical oxygen and respiratory care is an essential part of resilient and sustainable health systems and a critical element of pandemic preparedness. Investments in oxygen delivery systems will save lives now and build surge capacity for countries to respond against future health threats,” said Peter Sands, Executive Director of the Global Fund.

Severe shortages of medical oxygen have been a problem for decades in many low- and middle- income countries (LMICs) and less than 50 percent of health facilities have uninterrupted access to medical oxygen. This has deadly consequences for the most vulnerable; for example, of the 7.2 million children with pneumonia in critical need of medical oxygen each year in LMICs, only one in five children will receive it. The COVID-19 pandemic exacerbated these chronic shortages, leading to many preventable deaths and straining already fragile health systems.

“Availability of medical oxygen can be a matter of life and death that requires deliberate political commitment. I stared at death when I was diagnosed with COVID-19 due to delayed access to oxygen therapy owing to cost and inadequate supply. Families experienced preventable deaths that would have been averted with availability of affordable medical oxygen. Without the prioritization and sustained support from governments, access to this crucial resource will remain a hindrance to provision of quality health care and efforts in saving lives.” Said Maurine Murenga, Executive Director, Lean On Me Foundation and the Communities Constituency for GO2AL.

GO2AL calls on governments and health systems to:

  • prioritize access to medical oxygen in health strategies, policies, and financing in support of universal health coverage and pandemic prevention, preparedness and response.
  • ensure that people (especially children and newborns) with pneumonia or other respiratory and critical illnesses, pregnant women and surgical patients, have reliable access to medical oxygen therapy.
  • develop comprehensive guidance for the use of medical oxygen for tuberculosis patients to support holistic care.

Access to a sustainable, reliable supply of medical oxygen in low- and middle-income countries is critical to achieving the health-related targets of the Sustainable Development Goals by 2030, particularly to achieving universal health coverage, supporting pandemic preparedness, prevention and response, and ending epidemics including tuberculosis.

Additional quotes from GO2AL members:

“The pandemic highlighted how important it is to guarantee access to a sustainable, reliable supply of medical oxygen in LMICs. This is a crucial aspect to achieve universal coverage and access, based on a strong and renewed primary health care.” said Jarbas Barbosa da Silva Jr., Director of PAHO.

“The COVID-19 pandemic has laid bare a long-ignored aspect of health capacity in LMICs. Therefore, sustainable investments in medical oxygen must be prioritized in the ongoing global discussion on pandemic prevention, preparedness and response and universal health coverage,” said H.E. Dr. Jean Kaseya, Director General of Africa CDC.

Editor’s note: For more information about this call to action, please see the GO2AL briefing note titled “Medical Oxygen: Essential for saving lives today and tomorrow”.

For more information about GO2AL and its new Strategy: executive summary, please visit the GO2AL website.

About GO2AL

During the COVID-19 pandemic in February 2021, amidst widespread global oxygen shortages, the world’s leading health agencies created the Oxygen Emergency Taskforce as part of the Access to COVID-19 Tools Accelerator (ACT-Accelerator). The taskforce raised more than US$1 billion to boost access to medical oxygen, expand production, negotiate for better pricing, and provide technical advice to governments. As the world transitioned from the acute phase of the COVID-19 pandemic and prepares for future health threats, the ACT-Accelerator Oxygen Emergency Taskforce evolved in May 2023 into the Global Oxygen Alliance (GO2AL), a broader partnership of about 20 health agencies and representatives from civil society and affected communities to convert the investments made during the pandemic into lives saved and to expand the work started by the taskforce.

GO2AL members include the Access to Medicine Foundation; Africa Centres for Disease Control and Prevention; the Bill & Melinda Gates Foundation; Build Health International; the Clinton Health Access Initiative; the Every Breath Counts Coalition; Pan American Health Organization, Partners In Health; PATH; Save the Children; the Global Fund to Fight AIDS, Tuberculosis and Malaria; UNICEF; Unitaid; UNOPS; the United States Agency for International Development; the World Health Organization; the World Bank; and representatives from civil society and affected communities. New members, including representation from LMICs, are being invited as GO2AL strives to build a stronger, more diverse, and inclusive membership.

Media contact:

For more information and media requests:

Hervé Verhoosel

Head of Communications and Spokesperson

M: +33 6 22 59 73 54

verhooselh@unitaid.who.int

Pandémies : prévention, préparation et riposte

Equitable access to therapeutics for pandemic preparedness and response

Global Oxygen Alliance launched to boost access to life saving oxygen

Geneva – Oxygen, a life-saving medicine to treat acute respiratory illnesses like COVID-19 and pneumonia, is essential for surgery, trauma, emergency and critical care, and treating older persons, pregnant women and newborns. Medical oxygen is also proving to be a critical tool in pandemic preparedness as the world braces itself for potential future outbreaks of respiratory diseases.

The COVID-19 pandemic, which left many patients literally gasping for air, exacerbated chronic shortages of medical oxygen in low- and middle-income countries, leading to many preventable deaths and straining the already fragile health systems.

Even before COVID-19 swept across the world, nine in ten hospitals in low- and middle-income countries were unable to provide oxygen therapy, resulting in as many as 800,000 preventable deaths each year.

Against this backdrop, the Oxygen Emergency Taskforce of the Access to COVID-19 Tools Accelerator (ACT-A) was launched in February 2021 to coordinate the response of multilateral agencies and mobilize grant financing to help low and middle-income countries deal with acute oxygen shortages.

As WHO declares an end to COVID-19 as a global health emergency, a new Global Oxygen Alliance (GO2AL) is launched by global health partners to continue the essential work of the ACT-A Oxygen Emergency Taskforce, which raised more than US$1 billion to boost access to medical oxygen, including financing to expand production, lower the price of oxygen and provide technical support to governments. Taskforce achievements include negotiating ground-breaking agreements with the world’s two largest medical oxygen suppliers, drawing up plans to increase regional production of oxygen in low- and middle-income countries, and helping more than 100 countries to upgrade their treatment facilities.

GO2AL is designed to provide sustained support for low- and middle-income countries to fill yawning gaps in the availability and supply of medical oxygen. A core objective of GO2AL is to support countries with technical cooperation, financial solutions, capacity building, and demand-generation, to ensure that investments in oxygen systems made during the COVID-19 crisis are sustained. GO2AL will also engage in political advocacy and give a voice to those making oxygen systems work on the ground and those who need it.

“The case for scaling up oxygen therapy is overwhelming,” said Unitaid’s Executive Director Philippe Duneton. “More than one million people die each year from hypoxemia, or low blood oxygen, caused by conditions other than COVID-19, such as pneumonia, the leading cause of death among children under five. This is unacceptable and cannot go on.”

Access to medical oxygen also supports treatment of severe malaria, advanced HIV disease, and tuberculosis. Full access to oxygen, as well as pulse oximeters—portable devices that estimates the oxygen saturation of patient’s blood —could reduce mortality from all causes among hospitalized children by as much as 40 percent.

“Access to medical oxygen and respiratory care is a key component of a resilient and sustainable health system and a critical element of pandemic preparedness,” said Peter Sands, Executive Director of the Global Fund. “Our renewed alliance with global health partners will help ensure that high-quality medical oxygen services are accessible and affordable to all in low- and middle-income countries. Sustained investments in oxygen delivery systems will save lives now and build surge capacity against future threats.”

GO2AL is also closely collaborating with the Lancet Global Health Commission on Medical Oxygen Security, launched in September 2022 to address major gaps in oxygen research, mobilise a broad coalition to accelerate delivery of medical oxygen and reduce mortality and morbidity globally.

“Affected communities welcome the Global Oxygen Alliance initiative.  Through this platform we are confident that access to medical oxygen will be treated with the urgency it deserves,” said Maureen Murenga, Executive Director, Lean On Me Foundation and Communities Constituency, GO­2AL. “And that there will be global solidarity and political commitment embracing recent innovation to ensure that, regardless of anyone’s geographical location or economic status, we are able to access the much-needed life commodity.  We have the opportunity to save the millions of lives lost each year from hypoxemia.”

GO2AL was established in April 2023 with Unitaid and the Global Fund to Fight AIDS, Tuberculosis and Malaria as Co-Chairs, the Pan American Health Organization (PAHO) and the Africa Centres for Disease Control and Prevention (Africa CDC) as Vice-Chairs, and the World Health Organization (WHO), UNICEF and Unitaid sharing the secretariat.

Members of the ACT-A Oxygen Emergency Task Force have chosen to join GO2AL, including: Access to Medicine Foundation; Africa CDC; Bill and Melinda Gates Foundation; Clinton Health Access Initiative; The Every Beath Counts Coalition; The Global Fund to Fight AIDS, Tuberculosis and Malaria; PAHO; PATH; Save the Children; UNICEF; Unitaid; UNOPS; USAID; WHO; and the World Bank. New members, including representation from low- and middle-income countries, civil society and communities, are being invited as GO2AL strives to build a stronger and a more diverse and inclusive membership.

Related publications:

  • For more information about GO2AL and its new Strategy: executive summary, please visit the GO2AL website.
  • For more information about GO2AL’s launch event, please click here.

Check out the Photo Album from the launch session:

Increasing access to medical oxygen: Action to ensure sustained gains

Media contact:

For more information and media requests:

Hervé Verhoosel

Team Lead, Communications

M: +33 6 22 59 73 54

verhooselh@unitaid.who.int

Notes to editors:

Unitaid is a global health agency engaged in finding innovative solutions to prevent, diagnose, and treat diseases more quickly, affordably, and effectively, in low- and middle-income countries. Its work includes funding initiatives to address major diseases such as HIV, malaria, tuberculosis, cervical cancer, hepatitis C and other priority health conditions affecting women and children. Unitaid is now applying its expertise to address challenges in advancing new therapies and diagnostics for pandemic prevention, preparedness and response, building on its leadership role in the Access to COVID-19 Tools (ACT) Accelerator. Unitaid is hosted by the World Health Organization.

The Global Fund is a worldwide partnership to defeat HIV, TB and malaria and ensure a healthier, safer, more equitable future for all. We raise and invest more than US$4 billion a year to fight the deadliest infectious diseases, challenge the injustice which fuels them and strengthen health systems in more than 100 of the hardest hit countries. Since the beginning of the COVID-19 pandemic, we have invested an additional US$5 billion to fight the new pandemic and reinforce systems for health. We unite world leaders, communities, civil society, health workers and the private sector to find solutions that have the most impact, and we take them to scale worldwide. Since 2002, the Global Fund partnership has saved 50 million lives.

Africa CDC is a continental autonomous health agency of the African Union (AU) established to support public health initiatives of AU Member States and strengthen the capacity of public health institutions to detect, prevent, control and respond quickly and effectively to disease threats. Africa CDC serves Member States through the AU New Public Health Order which calls for action-oriented respectful partnership as one its core pillars.

The Pan American Health Organization (PAHO) is the specialized international health agency for the Americas, and serves as the Regional Office for the Americas of the World health Organization. It works with countries throughout the region to improve and protect people’s health. PAHO engages in technical cooperation with its member countries to fight communicable and noncommunicable diseases and their causes, to strengthen health systems, and to respond to emergencies and disasters. It has 35 Member States and four Associate Members in the region. Under their leadership, PAHO sets regional health priorities and mobilizes action to address health problems that respect no borders and that, in many cases, jeopardize the sustainability of health systems. From its Washington, D.C., headquarters, 27 country offices and three specialized centers in the region, PAHO promotes evidence-based decision-making to improve and promote health as a driver of sustainable development. Additional info: https://www.paho.org/en/who-we-are

UNICEF works in the world’s toughest places to reach the most disadvantaged children and adolescents – and to protect the rights of every child, everywhere. Across more than 190 countries and territories, we do whatever it takes to help children survive, thrive and fulfill their potential, from early childhood through adolescence. The world’s largest provider of vaccines, we support child health and nutrition, safe water and sanitation, quality education and skill building, HIV prevention and treatment for mothers and babies, and the protection of children and adolescents from violence and exploitation.Before, during and after humanitarian emergencies, UNICEF is on the ground, bringing lifesaving help and hope to children and families. Non-political and impartial, we are never neutral when it comes to defending children’s rights and safeguarding their lives and futures. Additional information: https://www.unicef.org/what-we-do

The World Health Organization provides global leadership in public health within the United Nations system. Founded in 1948, WHO works with 194 Member States across six regions, to promote health, keep the world safe and serve the vulnerable. Our goal for 2019-2023 is to ensure that a billion more people have universal health coverage, to protect a billion more people from health emergencies, and provide a further billion people with better health and well-being.  For updates on COVID-19 and public health advice to protect yourself from coronavirus, visit www.who.int and follow WHO on Twitter, Facebook, Instagram, LinkedIn, TikTok, Pinterest, Snapchat, YouTube, Twitch. Additional information on WHO’s work on oxygen: www.who.int/health-topics/oxygen.

Contact WHO Media Team: mediainquiries@who.int

Better health solutions

Unitaid’s investment case 2023-2027

Améliorer l’accès aux nouveaux traitements contre la COVID-19 : Lancement d’un rapport d’information à l’intention des États membres sur la manière de gérer les interfaces entre la santé publique et la propriété intellectuelle

Genève, le 11 avril 2023 – L’Organisation mondiale de la Santé (OMS) et Unitaid, avec l’appui de Medicines Law and Policy, ont publié aujourd’hui un document d’information visant à appuyer l’accès des pays à des traitements abordables contre la COVID-19.

Ce document d’information est une présentation factuelle de certains des instruments juridiques que les États Membres de l’OMS peuvent utiliser pour promouvoir la santé publique et l’accès aux traitements contre la COVID-19 dans le cadre de leurs obligations et droits commerciaux multilatéraux, et en fonction de leur législation nationale et de leur niveau de développement. Il vise à soutenir les pays confrontés à des enjeux situés à l’intersection de la santé publique et de la propriété intellectuelle, à améliorer l’accès aux nouveaux traitements contre la COVID-19 et à faciliter, dans la mesure du possible, la mise en place d’autres sources d’approvisionnement, plus abordables, pour ces traitements.

Les États Membres devraient utiliser tous les outils dont ils disposent et ce document d’information explique clairement quels sont ces outils, notamment les licences volontaires, pour surmonter les obstacles liés à la propriété intellectuelle. Les pays qui ne bénéficient pas des licences volontaires sont encouragés à se prévaloir des flexibilités prévues par l’Accord sur les aspects des droits de propriété intellectuelle qui touchent au commerce (Accord sur les ADPIC) et des dispositions de la Déclaration de Doha sur l’Accord sur les ADPIC et la santé publique.

La professeure Hanan Balkhy, Sous-Directrice générale de l’OMS, a déclaré : « J’invite instamment les États Membres à mettre en œuvre tous les outils dont ils disposent pour rendre possible la production locale et améliorer l’accès. Cela comprend les licences d’accès, l’application des flexibilités prévues par l’Accord sur les ADPIC et la mise en œuvre de la Décision de l’OMC sur les ADPIC. L’OMS continuera de fournir une assistance technique sur la manière d’utiliser ces instruments ».

Le Dr Philippe Duneton, Directeur exécutif d’UNITAID, a ajouté : « Il est primordial d’accorder la priorité à la disponibilité et à l’accessibilité des technologies de santé essentielles dans le monde entier. En exploitant tous les outils à notre disposition, nous pouvons améliorer l’accès aux produits de santé essentiels et, in fine, sauver davantage de vies. Chez Unitaid, nous demeurons déterminés à collaborer avec nos partenaires afin d’explorer toutes les solutions qui nous permettront de relever les défis posés par la pandémie et de construire un système de santé plus résilient pour l’avenir ».

Le document d’information contient des informations générales et des ressources sur les différents traitements et les recommandations de l’OMS (section 2) ; un aperçu des licences du Medicines Patent Pool pour les antiviraux oraux et les conséquences en termes d’accès des pays (section 3) ; le Groupement d’accès aux technologies contre la COVID-19 de l’OMS (section 4) ; d’autres licences pertinentes pour les traitements contre la COVID-19 (section 5) ; et des orientations sur l’utilisation des flexibilités prévues par l’Accord sur les ADPIC (section 6).

De nombreux pays à revenu intermédiaire ne bénéficient pas des licences volontaires existantes pour les nouveaux traitements contre la COVID-19, de sorte qu’ils ne peuvent pas bénéficier de versions génériques abordables des traitements recommandés par l’OMS. L’Organisation invite les détenteurs de technologies à étendre la portée géographique de ces licences pour permettre la concurrence et des réductions de prix afin que ces traitements importants puissent être utilisés là où ils sont le plus nécessaires.

Lisez le rapport :

À propos d’Unitaid

Unitaid est une agence de santé mondiale qui s’emploie à trouver des solutions innovantes pour prévenir, diagnostiquer et traiter les maladies plus rapidement, plus efficacement et à moindre coût dans les pays à revenu faible et intermédiaire. Elle finance notamment des initiatives visant à lutter contre de grandes maladies telles que le VIH/SIDA, le paludisme et la tuberculose, mais aussi contre les co-infections et comorbidités liées au VIH, comme le cancer du col de l’utérus et l’hépatite C. L’organisation soutient en outre des projets qui ciblent des domaines transversaux, tels que le traitement de la fièvre. En tant qu’acteur clé du Dispositif pour accélérer l’accès aux outils de lutte contre la COVID-19, Unitaid mobilise désormais son expertise pour répondre aux défis posés par le développement de nouvelles thérapies et de nouveaux diagnostics pour lutter contre la pandémie de COVID-19. Unitaid est un partenariat hébergé par l’Organisation mondiale de la Santé.

Contact pour les médias :

Pour plus d’information ou pour des demandes des médias, veuillez contacter :

Maxime Paquin

Chargé de communication

M: +41 79 516 56 00

paquinm@unitaid.who.int

Overview of mpox antivirals and diagnostics landscape